- Capital Cube•10 months ago
Click here to see latest analysisPharmaxis Ltd. reports financial results for the quarter ended December 31, 2015.HighlightsGross margins narrowed from 4.57% to -126.60% compared to the same period last year, operating (EBITDA) margins now -465.67% from -465.84%.Earnings growth from operating margin improvements as well as one-time items.The table below shows the preliminary results and recent […] (Read more...) The post Pharmaxis Ltd. :PXS-AU: Earnings Analysis: Q2, 2016 By the Numbers appeared first on CapitalCube.
- Motley Fool•3 years ago
Is this a new beginning for Bionomics?
We're sorry this is all we were able to find about this topic.
PXS.AX : Summary for PHARMAXIS FPO - Yahoo Finance
Pharmaxis Ltd (PXS.AX)
ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
|Day's Range||0.28 - 0.30|
|52 Week Range||0.23 - 0.34|
|PE Ratio (TTM)||-6.33|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|